A case series of pyrazinamide mono-resistant mycobacterium tuberculosis using whole genome sequencing for diagnosis and cluster linkage.

D. Braganza Menezes (Birmingham, United Kingdom), S. Lugg (Birmingham, United Kingdom), G. Hawthorne (Birmingham, United Kingdom), E. Robinson (Birmingham, United Kingdom), M. Dedicoat (Birmingham, United Kingdom)

Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Session: Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Session type: Thematic Poster
Number: 4755
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Braganza Menezes (Birmingham, United Kingdom), S. Lugg (Birmingham, United Kingdom), G. Hawthorne (Birmingham, United Kingdom), E. Robinson (Birmingham, United Kingdom), M. Dedicoat (Birmingham, United Kingdom). A case series of pyrazinamide mono-resistant mycobacterium tuberculosis using whole genome sequencing for diagnosis and cluster linkage.. 4755

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013

Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


Identification of isoniazid mono-resistance is delayed despite whole genome sequencing
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Molecular fingerprinting of mycobacterium tuberculosis isolates in new cases of tuberculosis using mycobacterial interspersed repetitive unit–variable number tandem repeat genotyping (MIRU-VNTR) – Epidemiology of drug resistant tuberculosis in Greece
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020

Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Whole genome sequencing of Mycobacterium tuberculosis
Source: Eur Respir J, 52 (5) 1801163; 10.1183/13993003.01163-2018
Year: 2018



Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak
Source: Eur Respir J, 51 (6) 1702313; 10.1183/13993003.02313-2017
Year: 2018



Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005


Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013

Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting
Source: Eur Respir J 2005; 26: Suppl. 49, 655s
Year: 2005

Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST.
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017


Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan
Source: Eur Respir J 2009; 33: 368-374
Year: 2009



Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS)
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016


DNA fingerprinting of mycobacterium tuberculosis strains in soldier patients by spoligotyping method
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008


Molecular genotyping of the clinical isolates of mycobacterium tuberculosis in Ukraine
Source: Eur Respir J 2006; 28: Suppl. 50, 848s
Year: 2006

Mutation analysis and treatment outcomes of Isoniazid monoresistant tuberculosis
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008